We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
- Authors
Opitz, Christiane A; Litzenburger, Ulrike M; Sahm, Felix; Ott, Martina; Tritschler, Isabel; Trump, Saskia; Schumacher, Theresa; Jestaedt, Leonie; Schrenk, Dieter; Weller, Michael; Jugold, Manfred; Guillemin, Gilles J; Miller, Christine L; Lutz, Christian; Radlwimmer, Bernhard; Lehmann, Irina; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael
- Abstract
Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals, for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety of cellular processes such as embryogenesis, transformation, tumorigenesis and inflammation. But the identity of an endogenous ligand activating the AHR under physiological conditions in the absence of environmental toxic chemicals is still unknown. Here we identify the tryptophan (Trp) catabolite kynurenine (Kyn) as an endogenous ligand of the human AHR that is constitutively generated by human tumour cells via tryptophan-2,3-dioxygenase (TDO), a liver- and neuron-derived Trp-degrading enzyme not yet implicated in cancer biology. TDO-derived Kyn suppresses antitumour immune responses and promotes tumour-cell survival and motility through the AHR in an autocrine/paracrine fashion. The TDO-AHR pathway is active in human brain tumours and is associated with malignant progression and poor survival. Because Kyn is produced during cancer progression and inflammation in the local microenvironment in amounts sufficient for activating the human AHR, these results provide evidence for a previously unidentified pathophysiological function of the AHR with profound implications for cancer and immune biology.
- Publication
Nature, 2011, Vol 478, Issue 7368, p197
- ISSN
1476-4687
- Publication type
Journal Article
- DOI
10.1038/nature10491